PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-55

  1. 6,010 Posts.
    lightbulb Created with Sketch. 1153
    still coming is my guess.... snippet from the worldsymposium webpage

    upload_2024-2-13_17-54-9.png
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.